Tag
Pharmaceuticals
-
Tariffs and meds: What health journalists should watch for now
The story of tariffs on medications has shifted quickly in recent weeks due to new trade agreements, industry reactions and…
-
A year later, the Inflation Reduction Act is about to take on rising drug costs
On the one-year anniversary of the Inflation Reduction Act, CMS is poised to begin negotiating prices for the 10 most…
-
Hospitals, HHS each scored a win and a loss in recent Supreme Court cases
Amid issuing some of the most significant rulings this century, the U.S. Supreme Court (SCOTUS) also decided on two cases…
-
Panel learns why there’s no easy fix for high drug prices
One of the best sessions at Health Journalism 2019 in Baltimore was the panel discussion about drug prices on May…
-
ACA limits Medicare’s use of key value metric for drug prices
Health insurers are trying a wide variety of methods to link drug costs to the value medications deliver to patients.…
-
•
Looking ahead to reporting on aging in the new year
There are plenty of aging-related stories on the horizon for 2015. Here are just some issues and ideas to get…
-
Researchers ‘owe’ the public information about financial ties #ahcj14
When writing about medical studies, reporters should always ask researchers about any financial relationships with drug companies or device manufacturers.…
-
CMS withdraws contentious parts of proposal to change prescription drug program
Perhaps the federal Centers for Medicare & Medicaid Services (CMS) learned a lesson over the past few weeks when it…
-
House committee grills CMS executive on proposal to revise Medicare drug plan
A plan from the federal Centers for Medicare & Medicaid Services to eliminate protections for certain classes of drugs ran…
-
Seeking to contain costs for six protected drug classes, CMS faces wide opposition
Patient care advocates, drug companies, and both Republicans and Democrats are arguing against a proposal from the federal Centers for…